CFF, C. (2016) “Health Canada alerta pacientes sobre os riscos do CRESTOR® (rosuvastatina)”, Farmacoterapêutica, 10(04), p. 6. Available at: https://revistas.cff.org.br/farmacoterapeutica/article/view/1530 (Accessed: 1 September 2024).